Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Dalton Pharma Services (Dalton), a privately-owned Canadian pharmaceutical services provider, has announced the successful completion of its recent Health Canada audit. The company has received a 'compliant' rating following the regulatory agency's inspection of it's GMP manufacturing facility.
Subscribe to our email newsletter
The Establishment License issued by Health Canada will enable Dalton to continue to manufacture, test and ship sterile commercial products for its existing clients. In addition, Dalton’s solid dose manufacturing suites were also inspected and found to be compliant for formulation, granulation and encapsulation of drug products.
In separate audits by Qualified Persons, Dalton was also found to be compliant with GMP API manufacturing, sterile filling and testing standards for pharmaceutical products in the EU.
Peter Pekos, president and CEO of Dalton Pharma Services, said: “These successful inspections will allow us to continue to execute on our vision to accelerate drug development for our clients’ pharmaceutical products globally.
“Dalton’s ability to carry out commercial manufacture of sterile, solid dose pharmaceuticals and API provides integrated drug development and manufacturing solutions. Dalton’s reputation for its ability to complete complex drug manufacturing projects in GMP compliant facilities enhances our clients’ success in bringing the medicines of the future to the market.”